|
||||||||||||
DHA, Council of Queensland Institute of Medical Research sign MoU for cancer research |
||||||||||||
|
The Dubai Health Authority, DHA, has signed a Memorandum of Understanding, MoU, with the Council of the Queensland Institute of Medical Research, QIMR Berghofer Medical Research Institute, to help secure the future of cancer research and treatment in Dubai. Humaid Al Qutami, Chairman of the Board and Director-General of the DHA, and Professor Frank Gannon, Director and CEO of QIMR Berghofer Medical Research Institute, today signed the MoU in the presence of Deputy Premier, Treasurer and Minister for Aboriginal and Torres Strait Islander Partnerships, Jackie Trad. The MoU was signed with the aim of establishing strong and collaborative research and training links in cancer diagnosis and treatment. Following the signing, Al Qutami said that the MoU is an important step, especially as it documents DHA's relationship with one of the world's leading research institutes, which will, in turn, support the authority’s drive to achieve a qualitative shift in medical research, clinical medicine and diagnostics, as well as professional development programmes, training and medical education. Al Qutami added that the MoU will also help in transferring knowledge and exchanging experiences between the two parties. Professor Gannon, in turn, said that the partnership would focus on clinical research and translation and on participating in developing a world-leading healthcare system using precision medicine techniques developed by QIMR Berghofer. "Our researchers have been able to develop genome-based diagnostic approaches that have the potential to revolutionise the diagnosis, treatment and management of cancer," Professor Gannon said. Professor Gannon said that under the agreement, the two parties will work together using new technologies, such as the integrated Cancer Recurrence Score test developed by the head of QIMR Berghofer’s Personalised Medicine Team, Associate Professor Fares Al-Ejeh. |
||||||||||||
